{
    "name": "atovaquone",
    "comment": "Rx",
    "other_names": [
        "Mepron"
    ],
    "classes": [
        "Antimalarials"
    ],
    "source": "https://reference.medscape.com/drug/mepron-atovaquone-342686",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: excretion in milk unknown; use with caution"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: excretion in milk unknown; use with caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "History of hypersensitivity reactions (e.g., angioedema, bronchospasm, throat tightness, urticaria) to drug or components"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Oral absorption is limited but can be significantly increased when drug is taken with food; failure to administer with food may result in lower plasma concentrations and may limit response to therapy; consider therapy with other agents in patients who have difficulty taking oral suspension with food or in patients who have gastrointestinal disorders that may limit absorption of oral medications",
                "Cases of cholestatic hepatitis, elevated liver enzymes, and fatal liver failure reported; if treating patients with severe hepatic impairment, closely monitor patients",
                "Hypersensitivity reactions reported, including bronchospasm, angioedema, urticaria and throat tightness"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "dapsone topical",
            "description": {
                "common": "atovaquone, dapsone topical. unspecified interaction mechanism. Avoid or Use Alternate Drug. Avoid coadministration of dapsone topical with oral dapsone or antimalarial medications because of the potential for hemolytic reactions."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "efavirenz",
            "description": {
                "common": "efavirenz decreases levels of atovaquone by unspecified interaction mechanism. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "bupivacaine implant",
            "description": {
                "common": "atovaquone, bupivacaine implant.\nEither increases toxicity of the other by Other (see comment). Use Caution/Monitor. \nComment: Local anesthetics may increase the risk of developing methemoglobinemia when concurrently exposed to drugs that also cause methemoglobinemia."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "indinavir",
            "description": {
                "common": "indinavir will decrease the level or effect of atovaquone by  unknown mechanism. Modify Therapy/Monitor Closely."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "metoclopramide intranasal",
            "description": {
                "common": "metoclopramide intranasal will increase the level or effect of atovaquone by  Other (see comment). Use Caution/Monitor. Metoclopramide may decrease the absorption of atovaquone. Monitor for reduced therapeutic effect of atovaquone."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "rifabutin",
            "description": {
                "common": "rifabutin decreases levels of atovaquone by increasing metabolism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "rifampin",
            "description": {
                "common": "rifampin decreases levels of atovaquone by increasing metabolism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "warfarin",
            "description": {
                "common": "atovaquone increases effects of warfarin by unspecified interaction mechanism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "metoclopramide",
            "description": {
                "common": "metoclopramide decreases levels of atovaquone by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "tetracycline",
            "description": {
                "common": "tetracycline decreases levels of atovaquone by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown. Effect may be minor, due to pharmacodynamic synergism."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Abdominal pain",
            "percent": "4-21"
        },
        {
            "name": "Cough",
            "percent": "14-25"
        },
        {
            "name": "Depression",
            "percent": "19-42"
        },
        {
            "name": "undefined",
            "percent": "15-21"
        },
        {
            "name": "Diarrhea",
            "percent": "14-40"
        },
        {
            "name": "Dyspnea",
            "percent": "16-31"
        },
        {
            "name": "Fever",
            "percent": "18-22"
        },
        {
            "name": "Headache",
            "percent": "10-19"
        },
        {
            "name": "Infection",
            "percent": "21-32"
        },
        {
            "name": "Insomnia",
            "percent": "22-46"
        },
        {
            "name": "Myalgia",
            "percent": "5-24"
        },
        {
            "name": "undefined",
            "percent": "14-22"
        },
        {
            "name": "Nausea",
            "percent": "8-31"
        },
        {
            "name": "Rash",
            "percent": "7-8"
        },
        {
            "name": "Rhinitis",
            "percent": "4-6"
        },
        {
            "name": "Vomiting",
            "percent": "7"
        },
        {
            "name": "Weakness",
            "percent": "7"
        },
        {
            "name": "Amylase increased",
            "percent": "1"
        },
        {
            "name": "Anemia",
            "percent": "3"
        },
        {
            "name": "Anorexia",
            "percent": "5"
        },
        {
            "name": "Anxiety",
            "percent": "3-8"
        },
        {
            "name": "BUN",
            "percent": "9"
        },
        {
            "name": "creatinine increased",
            "percent": "1"
        },
        {
            "name": "Constipation",
            "percent": "7-10"
        },
        {
            "name": "Dyspepsia",
            "percent": "4-8"
        },
        {
            "name": "Dizziness",
            "percent": "3-5"
        },
        {
            "name": "Hyperglycemia",
            "percent": "5-10"
        },
        {
            "name": "Hypoglycemia",
            "percent": "5-10"
        },
        {
            "name": "Hyponatremia",
            "percent": "3"
        },
        {
            "name": "Liver enzymes elevated",
            "percent": null
        },
        {
            "name": "Neutropenia",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "Oral moniliasis",
            "percent": null
        },
        {
            "name": "Taste perversion",
            "percent": null
        },
        {
            "name": "Blood and lymphatic system disorders",
            "percent": null
        },
        {
            "name": "Methemoglobinemia",
            "percent": null
        },
        {
            "name": "thrombocytopenia",
            "percent": null
        },
        {
            "name": "Immune system disorders",
            "percent": null
        },
        {
            "name": "Hypersensitivity reactions including angioedema",
            "percent": null
        },
        {
            "name": "bronchospasm",
            "percent": null
        },
        {
            "name": "throat tightness",
            "percent": null
        },
        {
            "name": "and urticaria",
            "percent": null
        },
        {
            "name": "Eye disorders",
            "percent": null
        },
        {
            "name": "Vortex keratopathy",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Pancreatitis",
            "percent": null
        },
        {
            "name": "Hepatobiliary disorders",
            "percent": null
        },
        {
            "name": "Hepatitis",
            "percent": null
        },
        {
            "name": "fatal liver failure",
            "percent": null
        }
    ]
}